nd3 Search Results


gene exp nd3 mm04225292 g1  (Thermo Fisher)
90
Thermo Fisher gene exp nd3 mm04225292 g1
Gene Exp Nd3 Mm04225292 G1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nd3/pmc07338799__EMMM___12___e11659___s001-1-19--1?v=Thermo+Fisher
Average 90 stars, based on 1 article reviews
gene exp nd3 mm04225292 g1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
anti nd3  (Novus Biologicals)
92
Novus Biologicals anti nd3
Anti Nd3, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nd3/pm37058569-300-14-17?v=Novus+Biologicals
Average 92 stars, based on 1 article reviews
anti nd3 - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier
gene exp mt nd3 rn03296825 s1  (Thermo Fisher)
85
Thermo Fisher gene exp mt nd3 rn03296825 s1
A: mt-ND1 was reduced ~3.7 fold in HT BN/SHR-mt SHR (*P<0.05). mt- <t>ND3</t> was reduced ~2.6 fold in HT SHR/BN-mt SHR (**P<0.01). mt-ND4 was reduced ~10.8 fold in HT SHR/BN-mt SHR (*P<0.05). mt-ND4L was reduced ~7.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND5 was reduced ~2.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND6 was reduced ~1.7 fold in HT SHR/BN-mt SHR (P>0.05) . mt-ND2 was not different between the two phenotypes (P>0.05). B: mt-CYB was reduced ~5 fold in HT BN/SHR-mt SHR (*P<0.05). C: mt-CO1 was reduced ~3.2 fold in HT BN/SHR-mt SHR (*P<0.05), mt-CO2 was reduced ~3.6 fold in HT BN/SHR-mt SHR (P<0.05), and mt-CO3 was reduced 4.1 fold in HT BN/SHR-mt SHR (P<0.05). D: mt-ATP6 was reduced ~2.3 fold in HT BN/SHR—mt SHR (*P<0.05), while mt-ATP8 was reduced ~3.1 fold in HT BN/SHR-mt SHR (*P<0.05). (NT: open bars; HT: closed bars).
Gene Exp Mt Nd3 Rn03296825 S1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nd3/pmc04550288-70-25--1?v=Thermo+Fisher
Average 85 stars, based on 1 article reviews
gene exp mt nd3 rn03296825 s1 - by Bioz Stars, 2026-07
85/100 stars
  Buy from Supplier
r46l rs11591147 nd 3  (Thermo Fisher)
86
Thermo Fisher r46l rs11591147 nd 3
A: mt-ND1 was reduced ~3.7 fold in HT BN/SHR-mt SHR (*P<0.05). mt- <t>ND3</t> was reduced ~2.6 fold in HT SHR/BN-mt SHR (**P<0.01). mt-ND4 was reduced ~10.8 fold in HT SHR/BN-mt SHR (*P<0.05). mt-ND4L was reduced ~7.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND5 was reduced ~2.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND6 was reduced ~1.7 fold in HT SHR/BN-mt SHR (P>0.05) . mt-ND2 was not different between the two phenotypes (P>0.05). B: mt-CYB was reduced ~5 fold in HT BN/SHR-mt SHR (*P<0.05). C: mt-CO1 was reduced ~3.2 fold in HT BN/SHR-mt SHR (*P<0.05), mt-CO2 was reduced ~3.6 fold in HT BN/SHR-mt SHR (P<0.05), and mt-CO3 was reduced 4.1 fold in HT BN/SHR-mt SHR (P<0.05). D: mt-ATP6 was reduced ~2.3 fold in HT BN/SHR—mt SHR (*P<0.05), while mt-ATP8 was reduced ~3.1 fold in HT BN/SHR-mt SHR (*P<0.05). (NT: open bars; HT: closed bars).
R46l Rs11591147 Nd 3, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nd3/pm20579540-50-2-23?v=Thermo+Fisher
Average 86 stars, based on 1 article reviews
r46l rs11591147 nd 3 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
nd3+-sensitized nir upconverting core-shell nanocrystals  (MicroStrain Inc)
90
MicroStrain Inc nd3+-sensitized nir upconverting core-shell nanocrystals
A: mt-ND1 was reduced ~3.7 fold in HT BN/SHR-mt SHR (*P<0.05). mt- <t>ND3</t> was reduced ~2.6 fold in HT SHR/BN-mt SHR (**P<0.01). mt-ND4 was reduced ~10.8 fold in HT SHR/BN-mt SHR (*P<0.05). mt-ND4L was reduced ~7.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND5 was reduced ~2.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND6 was reduced ~1.7 fold in HT SHR/BN-mt SHR (P>0.05) . mt-ND2 was not different between the two phenotypes (P>0.05). B: mt-CYB was reduced ~5 fold in HT BN/SHR-mt SHR (*P<0.05). C: mt-CO1 was reduced ~3.2 fold in HT BN/SHR-mt SHR (*P<0.05), mt-CO2 was reduced ~3.6 fold in HT BN/SHR-mt SHR (P<0.05), and mt-CO3 was reduced 4.1 fold in HT BN/SHR-mt SHR (P<0.05). D: mt-ATP6 was reduced ~2.3 fold in HT BN/SHR—mt SHR (*P<0.05), while mt-ATP8 was reduced ~3.1 fold in HT BN/SHR-mt SHR (*P<0.05). (NT: open bars; HT: closed bars).
Nd3+ Sensitized Nir Upconverting Core Shell Nanocrystals, supplied by MicroStrain Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nd3/pm38701381__nl4c01077_si_001-0-7-5?v=MicroStrain+Inc
Average 90 stars, based on 1 article reviews
nd3+-sensitized nir upconverting core-shell nanocrystals - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
nd3 99 atom% d  (Cambridge Isotope Laboratories)
90
Cambridge Isotope Laboratories nd3 99 atom% d
A: mt-ND1 was reduced ~3.7 fold in HT BN/SHR-mt SHR (*P<0.05). mt- <t>ND3</t> was reduced ~2.6 fold in HT SHR/BN-mt SHR (**P<0.01). mt-ND4 was reduced ~10.8 fold in HT SHR/BN-mt SHR (*P<0.05). mt-ND4L was reduced ~7.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND5 was reduced ~2.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND6 was reduced ~1.7 fold in HT SHR/BN-mt SHR (P>0.05) . mt-ND2 was not different between the two phenotypes (P>0.05). B: mt-CYB was reduced ~5 fold in HT BN/SHR-mt SHR (*P<0.05). C: mt-CO1 was reduced ~3.2 fold in HT BN/SHR-mt SHR (*P<0.05), mt-CO2 was reduced ~3.6 fold in HT BN/SHR-mt SHR (P<0.05), and mt-CO3 was reduced 4.1 fold in HT BN/SHR-mt SHR (P<0.05). D: mt-ATP6 was reduced ~2.3 fold in HT BN/SHR—mt SHR (*P<0.05), while mt-ATP8 was reduced ~3.1 fold in HT BN/SHR-mt SHR (*P<0.05). (NT: open bars; HT: closed bars).
Nd3 99 Atom% D, supplied by Cambridge Isotope Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nd3/10__1021_slash_acsearthspacechem__8b00169-37-5-9?v=Cambridge+Isotope+Laboratories
Average 90 stars, based on 1 article reviews
nd3 99 atom% d - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
diode pumped q-switched nd:yag laser nt242  (EKSPLA UAB)
90
EKSPLA UAB diode pumped q-switched nd:yag laser nt242
A: mt-ND1 was reduced ~3.7 fold in HT BN/SHR-mt SHR (*P<0.05). mt- <t>ND3</t> was reduced ~2.6 fold in HT SHR/BN-mt SHR (**P<0.01). mt-ND4 was reduced ~10.8 fold in HT SHR/BN-mt SHR (*P<0.05). mt-ND4L was reduced ~7.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND5 was reduced ~2.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND6 was reduced ~1.7 fold in HT SHR/BN-mt SHR (P>0.05) . mt-ND2 was not different between the two phenotypes (P>0.05). B: mt-CYB was reduced ~5 fold in HT BN/SHR-mt SHR (*P<0.05). C: mt-CO1 was reduced ~3.2 fold in HT BN/SHR-mt SHR (*P<0.05), mt-CO2 was reduced ~3.6 fold in HT BN/SHR-mt SHR (P<0.05), and mt-CO3 was reduced 4.1 fold in HT BN/SHR-mt SHR (P<0.05). D: mt-ATP6 was reduced ~2.3 fold in HT BN/SHR—mt SHR (*P<0.05), while mt-ATP8 was reduced ~3.1 fold in HT BN/SHR-mt SHR (*P<0.05). (NT: open bars; HT: closed bars).
Diode Pumped Q Switched Nd:Yag Laser Nt242, supplied by EKSPLA UAB, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nd3/pm36857707-155-24-30?v=EKSPLA+UAB
Average 90 stars, based on 1 article reviews
diode pumped q-switched nd:yag laser nt242 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
n-hexanoyl-l-homoserine lactone-d3 (nd3  (Merck KGaA)
90
Merck KGaA n-hexanoyl-l-homoserine lactone-d3 (nd3
A: mt-ND1 was reduced ~3.7 fold in HT BN/SHR-mt SHR (*P<0.05). mt- <t>ND3</t> was reduced ~2.6 fold in HT SHR/BN-mt SHR (**P<0.01). mt-ND4 was reduced ~10.8 fold in HT SHR/BN-mt SHR (*P<0.05). mt-ND4L was reduced ~7.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND5 was reduced ~2.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND6 was reduced ~1.7 fold in HT SHR/BN-mt SHR (P>0.05) . mt-ND2 was not different between the two phenotypes (P>0.05). B: mt-CYB was reduced ~5 fold in HT BN/SHR-mt SHR (*P<0.05). C: mt-CO1 was reduced ~3.2 fold in HT BN/SHR-mt SHR (*P<0.05), mt-CO2 was reduced ~3.6 fold in HT BN/SHR-mt SHR (P<0.05), and mt-CO3 was reduced 4.1 fold in HT BN/SHR-mt SHR (P<0.05). D: mt-ATP6 was reduced ~2.3 fold in HT BN/SHR—mt SHR (*P<0.05), while mt-ATP8 was reduced ~3.1 fold in HT BN/SHR-mt SHR (*P<0.05). (NT: open bars; HT: closed bars).
N Hexanoyl L Homoserine Lactone D3 (Nd3, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nd3/10__1007_slash_s00216___020___03040___6-53-11-22?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
n-hexanoyl-l-homoserine lactone-d3 (nd3 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
nd3+-doped core-shell nanocrystals  (Mingyuan Group)
90
Mingyuan Group nd3+-doped core-shell nanocrystals
A: mt-ND1 was reduced ~3.7 fold in HT BN/SHR-mt SHR (*P<0.05). mt- <t>ND3</t> was reduced ~2.6 fold in HT SHR/BN-mt SHR (**P<0.01). mt-ND4 was reduced ~10.8 fold in HT SHR/BN-mt SHR (*P<0.05). mt-ND4L was reduced ~7.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND5 was reduced ~2.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND6 was reduced ~1.7 fold in HT SHR/BN-mt SHR (P>0.05) . mt-ND2 was not different between the two phenotypes (P>0.05). B: mt-CYB was reduced ~5 fold in HT BN/SHR-mt SHR (*P<0.05). C: mt-CO1 was reduced ~3.2 fold in HT BN/SHR-mt SHR (*P<0.05), mt-CO2 was reduced ~3.6 fold in HT BN/SHR-mt SHR (P<0.05), and mt-CO3 was reduced 4.1 fold in HT BN/SHR-mt SHR (P<0.05). D: mt-ATP6 was reduced ~2.3 fold in HT BN/SHR—mt SHR (*P<0.05), while mt-ATP8 was reduced ~3.1 fold in HT BN/SHR-mt SHR (*P<0.05). (NT: open bars; HT: closed bars).
Nd3+ Doped Core Shell Nanocrystals, supplied by Mingyuan Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nd3/pm29800756-0-100-41?v=Mingyuan+Group
Average 90 stars, based on 1 article reviews
nd3+-doped core-shell nanocrystals - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
optically active sio 2 glasses  (Optics and Photonics)
90
Optics and Photonics optically active sio 2 glasses
A: mt-ND1 was reduced ~3.7 fold in HT BN/SHR-mt SHR (*P<0.05). mt- <t>ND3</t> was reduced ~2.6 fold in HT SHR/BN-mt SHR (**P<0.01). mt-ND4 was reduced ~10.8 fold in HT SHR/BN-mt SHR (*P<0.05). mt-ND4L was reduced ~7.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND5 was reduced ~2.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND6 was reduced ~1.7 fold in HT SHR/BN-mt SHR (P>0.05) . mt-ND2 was not different between the two phenotypes (P>0.05). B: mt-CYB was reduced ~5 fold in HT BN/SHR-mt SHR (*P<0.05). C: mt-CO1 was reduced ~3.2 fold in HT BN/SHR-mt SHR (*P<0.05), mt-CO2 was reduced ~3.6 fold in HT BN/SHR-mt SHR (P<0.05), and mt-CO3 was reduced 4.1 fold in HT BN/SHR-mt SHR (P<0.05). D: mt-ATP6 was reduced ~2.3 fold in HT BN/SHR—mt SHR (*P<0.05), while mt-ATP8 was reduced ~3.1 fold in HT BN/SHR-mt SHR (*P<0.05). (NT: open bars; HT: closed bars).
Optically Active Sio 2 Glasses, supplied by Optics and Photonics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nd3/pmc10298546-30-1-10?v=Optics+and+Photonics
Average 90 stars, based on 1 article reviews
optically active sio 2 glasses - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
nd3+-doped laf3 nanoparticles  (Jiangbo Pharmaceuticals)
90
Jiangbo Pharmaceuticals nd3+-doped laf3 nanoparticles
A: mt-ND1 was reduced ~3.7 fold in HT BN/SHR-mt SHR (*P<0.05). mt- <t>ND3</t> was reduced ~2.6 fold in HT SHR/BN-mt SHR (**P<0.01). mt-ND4 was reduced ~10.8 fold in HT SHR/BN-mt SHR (*P<0.05). mt-ND4L was reduced ~7.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND5 was reduced ~2.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND6 was reduced ~1.7 fold in HT SHR/BN-mt SHR (P>0.05) . mt-ND2 was not different between the two phenotypes (P>0.05). B: mt-CYB was reduced ~5 fold in HT BN/SHR-mt SHR (*P<0.05). C: mt-CO1 was reduced ~3.2 fold in HT BN/SHR-mt SHR (*P<0.05), mt-CO2 was reduced ~3.6 fold in HT BN/SHR-mt SHR (P<0.05), and mt-CO3 was reduced 4.1 fold in HT BN/SHR-mt SHR (P<0.05). D: mt-ATP6 was reduced ~2.3 fold in HT BN/SHR—mt SHR (*P<0.05), while mt-ATP8 was reduced ~3.1 fold in HT BN/SHR-mt SHR (*P<0.05). (NT: open bars; HT: closed bars).
Nd3+ Doped Laf3 Nanoparticles, supplied by Jiangbo Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nd3/10__1016_slash_s0009___2614_ascii40_10_ascii41_00429___x-14-0-11?v=Jiangbo+Pharmaceuticals
Average 90 stars, based on 1 article reviews
nd3+-doped laf3 nanoparticles - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


A: mt-ND1 was reduced ~3.7 fold in HT BN/SHR-mt SHR (*P<0.05). mt- ND3 was reduced ~2.6 fold in HT SHR/BN-mt SHR (**P<0.01). mt-ND4 was reduced ~10.8 fold in HT SHR/BN-mt SHR (*P<0.05). mt-ND4L was reduced ~7.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND5 was reduced ~2.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND6 was reduced ~1.7 fold in HT SHR/BN-mt SHR (P>0.05) . mt-ND2 was not different between the two phenotypes (P>0.05). B: mt-CYB was reduced ~5 fold in HT BN/SHR-mt SHR (*P<0.05). C: mt-CO1 was reduced ~3.2 fold in HT BN/SHR-mt SHR (*P<0.05), mt-CO2 was reduced ~3.6 fold in HT BN/SHR-mt SHR (P<0.05), and mt-CO3 was reduced 4.1 fold in HT BN/SHR-mt SHR (P<0.05). D: mt-ATP6 was reduced ~2.3 fold in HT BN/SHR—mt SHR (*P<0.05), while mt-ATP8 was reduced ~3.1 fold in HT BN/SHR-mt SHR (*P<0.05). (NT: open bars; HT: closed bars).

Journal: PLoS ONE

Article Title: Kidney-Specific Reduction of Oxidative Phosphorylation Genes Derived from Spontaneously Hypertensive Rat

doi: 10.1371/journal.pone.0136441

Figure Lengend Snippet: A: mt-ND1 was reduced ~3.7 fold in HT BN/SHR-mt SHR (*P<0.05). mt- ND3 was reduced ~2.6 fold in HT SHR/BN-mt SHR (**P<0.01). mt-ND4 was reduced ~10.8 fold in HT SHR/BN-mt SHR (*P<0.05). mt-ND4L was reduced ~7.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND5 was reduced ~2.7 fold in HT SHR/BN-mt SHR (P<0.05). mt-ND6 was reduced ~1.7 fold in HT SHR/BN-mt SHR (P>0.05) . mt-ND2 was not different between the two phenotypes (P>0.05). B: mt-CYB was reduced ~5 fold in HT BN/SHR-mt SHR (*P<0.05). C: mt-CO1 was reduced ~3.2 fold in HT BN/SHR-mt SHR (*P<0.05), mt-CO2 was reduced ~3.6 fold in HT BN/SHR-mt SHR (P<0.05), and mt-CO3 was reduced 4.1 fold in HT BN/SHR-mt SHR (P<0.05). D: mt-ATP6 was reduced ~2.3 fold in HT BN/SHR—mt SHR (*P<0.05), while mt-ATP8 was reduced ~3.1 fold in HT BN/SHR-mt SHR (*P<0.05). (NT: open bars; HT: closed bars).

Article Snippet: Pre-designed TaqMan primers and hydrolysis probes for all genes of interest were purchased from Applied Biosystems ( mt-ND1 - Rn03296764_s1, mt-ND2 - Rn03296765_s1, mt-ND3 - Rn03296825_s1, mt-ND4 - Rn03296781_s1, mt-ND4L - Rn03296792_s1, mt-ND5 - Rn03296799_s1, mt-ND6 - Rn03296815_s1, mt-CO1 - Rn03296721_s1, mt-CO2 - Rn03296737_s1, mt-CO3 - Rn03296820_s1, mt-CYB - Rn03296746_s1, mt-ATP6 - Rn03296710_s1, mt-ATP8 - Rn03296716_s1, NRF1 - Rn01455958_m1, NRF2a - Rn01767215_m1, NRF2b -Rn01514289_g1, Pgc1α -Rn00598552_m1, Tfam -Rn00580051_m1, Cyc1 -Rn01504159_g1, Cox6c -Rn00820983_gH, GAPDH - Rn01775763_g1).

Techniques: